Form 4: NYT Director Acquires Dividend Equivalent RSUs

Sentiment:

Insider Transaction Report


The New York Times Company director Anuradha B. Subramanian acquired 28 Class A Common Stock Restricted Stock Units as dividend equivalents.

Summary

  • Anuradha B. Subramanian, a Director of The New York Times Company, acquired 28 shares of Class A Common Stock on October 23, 2025.
  • These shares were Restricted Stock Units (RSUs) granted as Dividend Equivalent RSUs, issued in connection with cash dividends paid on existing Class A Common Stock.
  • The RSUs were acquired at a price of $0, indicating a grant rather than a purchase.
  • Following this transaction, Ms. Subramanian beneficially owns 9,573 shares of Class A Common Stock.
  • Dividend Equivalent RSUs granted for vested RSUs are immediately vested; those for unvested RSUs vest concurrently with the underlying unvested RSUs.

Sentiment

Score: 6

Explanation: The acquisition of dividend equivalent RSUs by a director is a routine event that slightly increases insider ownership, aligning the director's interests with shareholders. It is not a discretionary purchase, but rather a component of compensation.

Positives

  • Director Anuradha B. Subramanian increased her beneficial ownership in The New York Times Company by 28 shares of Class A Common Stock.
  • The acquisition of Dividend Equivalent RSUs aligns the director's interests further with those of shareholders, as these units are tied to cash dividends.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding the company's future performance.

Industry Context

This is a routine insider transaction for a director receiving compensation in the form of equity, specifically dividend equivalents. Such grants are common practice across publicly traded companies to align director incentives with shareholder value.

Comparison to Industry Standards

  • The practice of granting Restricted Stock Units (RSUs) as part of director compensation, including dividend equivalents, is a standard practice in corporate governance across various industries, including media companies. This aligns director interests with long-term shareholder value. No specific comparable companies or projects are mentioned in the filing.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Administrative AuthorizationA Power of Attorney, dated August 7, 2025, was granted by Anuradha B. Subramanian, authorizing specific individuals (Diane Brayton, Michael A. Brown, Elah Lanis, Amanda Schwarzenbart) to execute and file Section 16 reports (Forms ID, 3, 4, and 5) on her behalf.08/07/2025Streamlines compliance with SEC reporting requirements for insider transactions, ensuring timely and accurate disclosures.

Related Party Transactions

  • The acquisition of Dividend Equivalent RSUs by a director is a transaction between the company and a related party (director) as part of an established incentive compensation plan.

Stakeholder Impact

  • Shareholders: Minor positive impact due to increased alignment of a director's interests with shareholder value through equity ownership.

Key Dates

DateDescription
08/07/2025Date of Power of Attorney execution.
10/23/2025Date of the reported transaction (acquisition of RSUs).
10/27/2025Date the Form 4 was signed.

Recommendation

hold

This Form 4 reports a routine, non-discretionary acquisition of dividend equivalent Restricted Stock Units by a director. While it slightly increases insider ownership, which is generally a positive signal of alignment, it does not represent a significant discretionary investment or provide new material information about the company's financial performance or strategic direction that would warrant a change in investment recommendation. Therefore, a "hold" recommendation is appropriate based solely on this filing.

Keywords

The New York Times Company, NYT, Anuradha B. Subramanian, Director, Form 4, Insider Transaction, Restricted Stock Units, RSUs, Dividend Equivalent RSUs, Class A Common Stock, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.